Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its Direct-to-Consumer GlutenID test. GlutenID ...
Hosted on MSN12d
FDA grants 510(k) clearance to Targeted Genomics’ GlutenID test
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...
sicklecellanemianews3d
New stem cell transplant approach offers potential sickle cell cure
A new stem cell transplant type was effective for most patients in a clinical trial, pointing to its use as a potential ...
precisionmedicineonline3d
Indonesia to Kick Off PGx Program for Leprosy Patients With Singapore's NalaGenetics
The program will use NalaGenetics' PGx test to screen leprosy patients for the HLA-B*13:01 allele, which has been linked with a serious hypersensitivity reaction.
Nature2mon
Impact of MHC class I diversity on immune control of immunodeficiency virus replication
The outcome of HIV infection is strongly influenced by the particular HLA genes expressed by the infected individual. Certain HLA alleles, such as HLA-B57 and HLA-B27, are strongly associated with ...
EurekAlert!5d
A*STAR spin-off NalaGenetics implements nationwide drug reaction screening for leprosy patients in Indonesia
Nalagenetics, a spin-off from A*STAR GIS, will be implementing a nationwide genetic screening programme in Indonesia with their PGx1301 diagnostic kit for leprosy patients. Set to launch in the fourth ...